309 related articles for article (PubMed ID: 33390244)
1. Tumor Control Probability of Radiosurgery and Fractionated Stereotactic Radiosurgery for Brain Metastases.
Redmond KJ; Gui C; Benedict S; Milano MT; Grimm J; Vargo JA; Soltys SG; Yorke E; Jackson A; El Naqa I; Marks LB; Xue J; Heron DE; Kleinberg LR
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):53-67. PubMed ID: 33390244
[TBL] [Abstract][Full Text] [Related]
2. Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain.
Milano MT; Grimm J; Niemierko A; Soltys SG; Moiseenko V; Redmond KJ; Yorke E; Sahgal A; Xue J; Mahadevan A; Muacevic A; Marks LB; Kleinberg LR
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):68-86. PubMed ID: 32921513
[TBL] [Abstract][Full Text] [Related]
3. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic Radiosurgery for Vestibular Schwannomas: Tumor Control Probability Analyses and Recommended Reporting Standards.
Soltys SG; Milano MT; Xue J; Tomé WA; Yorke E; Sheehan J; Ding GX; Kirkpatrick JP; Ma L; Sahgal A; Solberg T; Adler J; Grimm J; El Naqa I
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):100-111. PubMed ID: 33375955
[TBL] [Abstract][Full Text] [Related]
5. Single- and Multi-Fraction Stereotactic Radiosurgery Dose Tolerances of the Optic Pathways.
Milano MT; Grimm J; Soltys SG; Yorke E; Moiseenko V; Tomé WA; Sahgal A; Xue J; Ma L; Solberg TD; Kirkpatrick JP; Constine LS; Flickinger JC; Marks LB; El Naqa I
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):87-99. PubMed ID: 29534899
[TBL] [Abstract][Full Text] [Related]
6. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
Loo M; Pin Y; Thierry A; Clavier JB
Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
[TBL] [Abstract][Full Text] [Related]
7. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic Body Radiation Therapy for Spinal Metastases: Tumor Control Probability Analyses and Recommended Reporting Standards.
Soltys SG; Grimm J; Milano MT; Xue J; Sahgal A; Yorke E; Yamada Y; Ding GX; Li XA; Lovelock DM; Jackson A; Ma L; El Naqa I; Gibbs IC; Marks LB; Benedict S
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):112-123. PubMed ID: 33516580
[TBL] [Abstract][Full Text] [Related]
9. Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer).
Lesueur P; Lequesne J; Barraux V; Kao W; Geffrelot J; Grellard JM; Habrand JL; Emery E; Marie B; Thariat J; Stefan D
Radiat Oncol; 2018 Jul; 13(1):138. PubMed ID: 30055640
[TBL] [Abstract][Full Text] [Related]
10. Fractionated stereotactic radiosurgery for malignant gliomas: comparison with single session stereotactic radiosurgery.
Choi SW; Cho KR; Choi JW; Kong DS; Seol HJ; Nam DH; Lee JI
J Neurooncol; 2019 Dec; 145(3):571-579. PubMed ID: 31705245
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of postoperative stereotactic radiosurgery to the resection cavity versus stereotactic radiosurgery alone for melanoma brain metastases.
Minniti G; Paolini S; D'Andrea G; Lanzetta G; Cicone F; Confaloni V; Bozzao A; Esposito V; Osti M
J Neurooncol; 2017 May; 132(3):455-462. PubMed ID: 28260130
[TBL] [Abstract][Full Text] [Related]
12. Impact of the radiosurgery prescription dose on the local control of small (2 cm or smaller) brain metastases.
Mohammadi AM; Schroeder JL; Angelov L; Chao ST; Murphy ES; Yu JS; Neyman G; Jia X; Suh JH; Barnett GH; Vogelbaum MA
J Neurosurg; 2017 Mar; 126(3):735-743. PubMed ID: 27231978
[TBL] [Abstract][Full Text] [Related]
13. Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort.
Balermpas P; Stera S; Müller von der Grün J; Loutfi-Krauss B; Forster MT; Wagner M; Keller C; Rödel C; Seifert V; Blanck O; Wolff R
PLoS One; 2018; 13(6):e0198692. PubMed ID: 29874299
[TBL] [Abstract][Full Text] [Related]
14. SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases.
Crouzen JA; Petoukhova AL; Broekman MLD; Fiocco M; Fisscher UJ; Franssen JH; Gadellaa-van Hooijdonk CGM; Kerkhof M; Kiderlen M; Mast ME; van Rij CM; Nandoe Tewarie R; van de Sande MAE; van der Toorn PPG; Vlasman R; Vos MJ; van der Voort van Zyp NCMG; Wiggenraad RGJ; Wiltink LM; Zindler JD
BMC Cancer; 2023 Mar; 23(1):273. PubMed ID: 36964529
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic Radiosurgery for Postoperative Metastatic Surgical Cavities: A Critical Review and International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines.
Redmond KJ; De Salles AAF; Fariselli L; Levivier M; Ma L; Paddick I; Pollock BE; Regis J; Sheehan J; Suh J; Yomo S; Sahgal A
Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):68-80. PubMed ID: 33891979
[TBL] [Abstract][Full Text] [Related]
16. Incidence of radionecrosis in single-fraction radiosurgery compared with fractionated radiotherapy in the treatment of brain metastasis.
Donovan EK; Parpia S; Greenspoon JN
Curr Oncol; 2019 Jun; 26(3):e328-e333. PubMed ID: 31285676
[TBL] [Abstract][Full Text] [Related]
17. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
[TBL] [Abstract][Full Text] [Related]
18. Leptomeningeal disease and brain control after postoperative stereotactic radiosurgery with or without immunotherapy for resected brain metastases.
Minniti G; Lanzetta G; Capone L; Giraffa M; Russo I; Cicone F; Bozzao A; Alongi F; Nicosia L; Fineschi G; Marchetti L; Tufo T; Bianciardi F; Esposito V; Gentile P; Paolini S
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34949695
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic radiosurgery of brain metastases: a retrospective study.
Gruber I; Weidner K; Treutwein M; Koelbl O
Radiat Oncol; 2023 Dec; 18(1):202. PubMed ID: 38115009
[TBL] [Abstract][Full Text] [Related]
20. Tumor Control Probability Modeling and Systematic Review of the Literature of Stereotactic Body Radiation Therapy for Prostate Cancer.
Royce TJ; Mavroidis P; Wang K; Falchook AD; Sheets NC; Fuller DB; Collins SP; El Naqa I; Song DY; Ding GX; Nahum AE; Jackson A; Grimm J; Yorke E; Chen RC
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):227-236. PubMed ID: 32900561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]